Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease
Sophia Sobesky, Laman Mammadova, Melita Cirillo, Esther Drees, Julia Mattlener, Helge Dörr, Janine Altmüller, Zhiyuan Shi, View ORCID ProfilePaul J Bröckelmann, Jonathan Weiss, Stefanie Kreissl, Stephanie Sasse, Roland T Ullrich, Sarah Reinke, Wolfram Klapper, Elena Gerhard-Hartmann, Andreas Rosenwald, Margaretha GM Roemer, Peter Nürnberg, Anton Hagenbeek, Josée M. Zijlstra, Dirk Michiel Pegtel, Andreas Engert, Peter Borchmann, Bastian von Tresckow, Sven Borchmann
doi: https://doi.org/10.1101/2021.03.16.21253679
Sophia Sobesky
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Laman Mammadova
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Melita Cirillo
4University of Western Australia and Royal Perth Hospital, Perth, Australia
Esther Drees
5Amsterdam UMC, Vrije Universiteit Amsterdam, Exosomes Research Group, Department of Pathology, Cancer Center Amsterdam, The Netherlands
6Amsterdam UMC, Vrije Universiteit Amsterdam, Dept of Hematology, Cancer Center Amsterdam, The Netherlands
Julia Mattlener
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Helge Dörr
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Janine Altmüller
7Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany
Zhiyuan Shi
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
Paul J Bröckelmann
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Jonathan Weiss
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
Stefanie Kreissl
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Stephanie Sasse
8Department IV of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, RWTH Aachen University, Germany
Roland T Ullrich
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
Sarah Reinke
9University Hospital Schleswig-Holstein, Campus Kiel, Germany
Wolfram Klapper
9University Hospital Schleswig-Holstein, Campus Kiel, Germany
Elena Gerhard-Hartmann
10Department of Pathology, University of Würzburg, Würzburg, Germany
11Comprehensive Cancer Center Mainfranken, Würzburg, Germany
Andreas Rosenwald
10Department of Pathology, University of Würzburg, Würzburg, Germany
11Comprehensive Cancer Center Mainfranken, Würzburg, Germany
Margaretha GM Roemer
6Amsterdam UMC, Vrije Universiteit Amsterdam, Dept of Hematology, Cancer Center Amsterdam, The Netherlands
Peter Nürnberg
7Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany
Anton Hagenbeek
6Amsterdam UMC, Vrije Universiteit Amsterdam, Dept of Hematology, Cancer Center Amsterdam, The Netherlands
Josée M. Zijlstra
6Amsterdam UMC, Vrije Universiteit Amsterdam, Dept of Hematology, Cancer Center Amsterdam, The Netherlands
Dirk Michiel Pegtel
5Amsterdam UMC, Vrije Universiteit Amsterdam, Exosomes Research Group, Department of Pathology, Cancer Center Amsterdam, The Netherlands
Andreas Engert
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Peter Borchmann
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Bastian von Tresckow
3German Hodgkin Study Group, Cologne, Germany
12Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK partner site Essen), Essen, Germany
13Cancer Center Cologne Essen – Partner Site Essen, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen
Sven Borchmann
1Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany
2Cancer Center Cologne Essen – Partner Site Cologne, CIO Cologne, University of Cologne, Germany
3German Hodgkin Study Group, Cologne, Germany
Data Availability
Primary sequencing data cannot be deposited publicly due to legal requirements and patient data protection. Upon entering a collaboration agreement and in consultation with the local ethics committee access to primary sequencing data might be granted. All secondary data derived from primary sequencing data is available within the article, supplementary information, or supplementary data files or available from the authors upon reasonable request.
Posted March 24, 2021.
Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease
Sophia Sobesky, Laman Mammadova, Melita Cirillo, Esther Drees, Julia Mattlener, Helge Dörr, Janine Altmüller, Zhiyuan Shi, Paul J Bröckelmann, Jonathan Weiss, Stefanie Kreissl, Stephanie Sasse, Roland T Ullrich, Sarah Reinke, Wolfram Klapper, Elena Gerhard-Hartmann, Andreas Rosenwald, Margaretha GM Roemer, Peter Nürnberg, Anton Hagenbeek, Josée M. Zijlstra, Dirk Michiel Pegtel, Andreas Engert, Peter Borchmann, Bastian von Tresckow, Sven Borchmann
medRxiv 2021.03.16.21253679; doi: https://doi.org/10.1101/2021.03.16.21253679
Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease
Sophia Sobesky, Laman Mammadova, Melita Cirillo, Esther Drees, Julia Mattlener, Helge Dörr, Janine Altmüller, Zhiyuan Shi, Paul J Bröckelmann, Jonathan Weiss, Stefanie Kreissl, Stephanie Sasse, Roland T Ullrich, Sarah Reinke, Wolfram Klapper, Elena Gerhard-Hartmann, Andreas Rosenwald, Margaretha GM Roemer, Peter Nürnberg, Anton Hagenbeek, Josée M. Zijlstra, Dirk Michiel Pegtel, Andreas Engert, Peter Borchmann, Bastian von Tresckow, Sven Borchmann
medRxiv 2021.03.16.21253679; doi: https://doi.org/10.1101/2021.03.16.21253679
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)